THE ANALYSIS STUDY OF EVALUATING THE EFFICACY AND SAFETY OF PERCUTANEUS CORONARY INTERVENTION (PCI) VERSUS EDTA (CHELATION THERAPY) FOR CORONARY ARTERY DISEASE : A COMPREHENSIVE SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/wtz83z86Keywords:
Coronary artery disease, EDTA, PCI, effectivenessAbstract
Background: Percutaneous coronary intervention (PCI) is a pivotal treatment for patients with stable coronary artery disease (CAD), yet its overall effectiveness remains limited. Despite technological advancements, only about 5% of patients receive PCI, comparable to the 5% who are treated with pharmacological therapies. The ongoing debate between PCI and optimal drug therapy (ODT) continues, with ethylenediaminetetraacetic acid (EDTA) emerging as a notable treatment alternative. This systematic review seeks to compare the outcomes of these interventions and offer guidance for clinical decision-making.
Methods: Adhering to PRISMA 2020 guidelines, this review focused on full-text articles published in English from 2012 to 2024. To ensure the inclusion of high-quality studies, editorial pieces and review articles were excluded unless they included a DOI. A comprehensive literature search was performed across several reputable databases, including ScienceDirect, PubMed, and SagePub, to collect relevant research thoroughly.
Result: The review analyzed over 800 publications from these databases. After an initial screening process, eight studies were selected for detailed examination. These selected studies underwent a rigorous review to ensure comprehensive and precise evaluation.
Conclusion: While both EDTA and PCI represent advanced treatment options for CAD, their effectiveness is contested due to their complexity and high costs. The systematic review indicates that PCI may offer greater benefits for patients with chronic total occlusions (CTO), showing lower mortality and myocardial infarction (MI) rates. Future research should prioritize large-scale clinical trials to further elucidate the comparative efficacy of PCI and EDTA.
References
Claessen, B. E., Dangas, G. D., Weisz, G., Witzenbichler, B., Guagliumi, G., Möckel, M., Brener, S. J., Xu, K., Henriques, J. P., Mehran, R., & Stone, G. W. (2012). Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. European heart journal, 33(6), 768–775. https://doi.org/10.1093/eurheartj/ehr471
Hoebers, L. P., Vis, M. M., Claessen, B. E., van der Schaaf, R. J., Kikkert, W. J., Baan, J., Jr, de Winter, R. J., Piek, J. J., Tijssen, J. G., Dangas, G. D., & Henriques, J. P. (2013). The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock. European journal of heart failure, 15(4), 425–432. https://doi.org/10.1093/eurjhf/hfs182
Azzalini, L., Jolicoeur, E. M., Pighi, M., Millán, X., Picard, F., Tadros, V. X., Fortier, A., L'Allier, P. L., & Ly, H. Q. (2016). Epidemiology, Management Strategies, and Outcomes of Patients With Chronic Total Coronary Occlusion. The American journal of cardiology, 118(8), 1128–1135. https://doi.org/10.1016/j.amjcard.2016.07.023
Brilakis, E. S., Banerjee, S., Karmpaliotis, D., Lombardi, W. L., Tsai, T. T., Shunk, K. A., Kennedy, K. F., Spertus, J. A., Holmes, D. R., Jr, & Grantham, J. A. (2015). Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC. Cardiovascular interventions, 8(2), 245–253. https://doi.org/10.1016/j.jcin.2014.08.014
Christakopoulos, G. E., Christopoulos, G., Carlino, M., Jeroudi, O. M., Roesle, M., Rangan, B. V., Abdullah, S., Grodin, J., Kumbhani, D. J., Vo, M., Luna, M., Alaswad, K., Karmpaliotis, D., Rinfret, S., Garcia, S., Banerjee, S., & Brilakis, E. S. (2015). Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. The American journal of cardiology, 115(10), 1367–1375. https://doi.org/10.1016/j.amjcard.2015.02.038
Hoebers, L. P., Claessen, B. E., Elias, J., Dangas, G. D., Mehran, R., & Henriques, J. P. (2015). Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. International journal of cardiology, 187, 90–96. https://doi.org/10.1016/j.ijcard.2015.03.164
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., Khot, U. N., Lange, R. A., Mauri, L., Mehran, R., Moussa, I. D., Mukherjee, D., Nallamothu, B. K., & Ting, H. H. (2011). 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 124(23), e574–e651. https://doi.org/10.1161/CIR.0b013e31823ba622
Kearney, K., Hira, R. S., Riley, R. F., Kalyanasundaram, A., & Lombardi, W. L. (2017). Update on the Management of Chronic Total Occlusions in Coronary Artery Disease. Current atherosclerosis reports, 19(4), 19. https://doi.org/10.1007/s11883-017-0655-0
Neumann, F. J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J. P., Falk, V., Head, S. J., Jüni, P., Kastrati, A., Koller, A., Kristensen, S. D., Niebauer, J., Richter, D. J., Seferovic, P. M., Sibbing, D., Stefanini, G. G., Windecker, S., … ESC Scientific Document Group (2019). 2018 ESC/EACTS Guidelines on myocardial revascularization. European heart journal, 40(2), 87–165. https://doi.org/10.1093/eurheartj/ehy394
Choi, S. Y., Choi, B. G., Rha, S. W., Baek, M. J., Ryu, Y. G., Park, Y., Byun, J. K., Shim, M., Li, H., Mashaly, A., Jang, W. Y., Kim, W., Choi, J. Y., Park, E. J., Na, J. O., Choi, C. U., Lim, H. E., Kim, E. J., Park, C. G., Seo, H. S., … Oh, D. J. (2017). Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well-Developed Collaterals. Journal of the American Heart Association, 6(9), e006357. https://doi.org/10.1161/JAHA.117.006357
Werner, G. S., Martin-Yuste, V., Hildick-Smith, D., Boudou, N., Sianos, G., Gelev, V., Rumoroso, J. R., Erglis, A., Christiansen, E. H., Escaned, J., di Mario, C., Hovasse, T., Teruel, L., Bufe, A., Lauer, B., Bogaerts, K., Goicolea, J., Spratt, J. C., Gershlick, A. H., Galassi, A. R., … EUROCTO trial investigators (2018). A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. European heart journal, 39(26), 2484–2493. https://doi.org/10.1093/eurheartj/ehy220
Choo, E. H., Koh, Y. S., Seo, S. M., Lee, J. M., Kim, H. Y., Park, H. J., Kim, P. J., Chang, K., Jeon, D. S., Kim, D. B., Her, S. H., Park, C. S., Yoo, K. D., Chung, W. S., & Seung, K. B. (2019). Comparison of successful percutaneous coronary intervention versus optimal medical therapy in patients with coronary chronic total occlusion. Journal of cardiology, 73(2), 156–162. https://doi.org/10.1016/j.jjcc.2018.08.006
King-Shier, K. M., Quan, H., Mather, C., Verhoef, M. J., Knutson, M. L., & Ghali, W. A. (2012). Understanding coronary artery disease patients' decisions regarding the use of chelation therapy for coronary artery disease: descriptive decision modeling. International journal of nursing studies, 49(9), 1074–1083. https://doi.org/10.1016/j.ijnurstu.2012.03.011
Seely, D. M., Wu, P., & Mills, E. J. (2005). EDTA chelation therapy for cardiovascular disease: a systematic review. BMC cardiovascular disorders, 5, 32. https://doi.org/10.1186/1471-2261-5-32
Lamas, G. A., & Hussein, S. J. (2006). EDTA chelation therapy meets evidence-based medicine. Complementary therapies in clinical practice, 12(3), 213–215. https://doi.org/10.1016/j.ctcp.2006.04.002
Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT Investigators. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA. 2013 Mar 27;309(12):1241-50. doi: 10.1001/jama.2013.2107. PMID: 23532240; PMCID: PMC4066975.
Escolar, E., Lamas, G. A., Mark, D. B., Boineau, R., Goertz, C., Rosenberg, Y., Nahin, R. L., Ouyang, P., Rozema, T., Magaziner, A., Nahas, R., Lewis, E. F., Lindblad, L., & Lee, K. L. (2014). The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circulation. Cardiovascular quality and outcomes, 7(1), 15–24. https://doi.org/10.1161/CIRCOUTCOMES.113.000663
Sultan, S., Murarka, S., Jahangir, A., Mookadam, F., Tajik, A. J., & Jahangir, A. (2017). Chelation therapy in cardiovascular disease: an update. Expert review of clinical pharmacology, 10(8), 843–854. https://doi.org/10.1080/17512433.2017.1339601
Ma, Y., Li, D., Li, J., Li, Y., Bai, F., Qin, F., Zhou, S., & Liu, Q. (2018). Percutaneous coronary intervention versus optimal medical therapy for patients with chronic total occlusion: a meta-analysis and systematic review. Journal of thoracic disease, 10(5), 2960–2967. https://doi.org/10.21037/jtd.2018.04.140
Juricic, S. A., Tesic, M. B., Galassi, A. R., Petrovic, O. N., Dobric, M. R., Orlic, D. N., Vukcevic, V. D., Stankovic, G. R., Aleksandric, S. B., Tomasevic, M. V., Nedeljkovic, M. A., Beleslin, B. D., Jelic, D. D., Ostojic, M. C., & Stojkovic, S. M. (2021). Randomized Controlled Comparison of Optimal Medical Therapy with Percutaneous Recanalization of Chronic Total Occlusion (COMET-CTO). International heart journal, 62(1), 16–22. https://doi.org/10.1536/ihj.20-427
Qian X, Deng H, Yuan J, Hu J, Dai L, Jiang T. Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis. J Thorac Dis. 2022 Apr;14(4):1183-1192. doi: 10.21037/jtd-22-222. PMID: 35572911; PMCID: PMC9096285.
Ravalli F, Vela Parada X, Ujueta F, Pinotti R, Anstrom KJ, Lamas GA, Navas-Acien A. Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review. J Am Heart Assoc. 2022 Mar 15;11(6):e024648. doi: 10.1161/JAHA.121.024648. Epub 2022 Mar 1. PMID: 35229619; PMCID: PMC9075296.
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., Franco, S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Huffman, M. D., Kissela, B. M., Kittner, S. J., Lackland, D. T., … American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2013). Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation, 127(1), e6–e245. https://doi.org/10.1161/CIR.0b013e31828124ad
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., King, S. B., 3rd, Kligfield, P. D., Krumholz, H. M., Kwong, R. Y., Lim, M. J., Linderbaum, J. A., Mack, M. J., Munger, M. A., Prager, R. L., Sabik, J. F., … American College of Cardiology Foundation/American Heart Association Task Force (2012). 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation, 126(25), e354–e471. https://doi.org/10.1161/CIR.0b013e318277d6a0
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., Di Mario, C., Ferreira, J. R., Gersh, B. J., Gitt, A. K., Hulot, J. S., Marx, N., Opie, L. H., Pfisterer, M., Prescott, E., Ruschitzka, F., … Zamorano, J. L. (2013). 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European heart journal, 34(38), 2949–3003. https://doi.org/10.1093/eurheartj/eht296
Risos, L., & Berkenboom, G. (2014). Revascularization versus medical treatments in stable coronary artery disease: predicting the future of novel drug therapies for stable angina. Journal of cardiovascular pharmacology, 63(3), 213–217. https://doi.org/10.1097/FJC.0000000000000051
Pijls, N. H., Fearon, W. F., Tonino, P. A., Siebert, U., Ikeno, F., Bornschein, B., van't Veer, M., Klauss, V., Manoharan, G., Engstrøm, T., Oldroyd, K. G., Ver Lee, P. N., MacCarthy, P. A., De Bruyne, B., & FAME Study Investigators (2010). Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. Journal of the American College of Cardiology, 56(3), 177–184. https://doi.org/10.1016/j.jacc.2010.04.012
Pursnani, S., Korley, F., Gopaul, R., Kanade, P., Chandra, N., Shaw, R. E., & Bangalore, S. (2012). Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circulation. Cardiovascular interventions, 5(4), 476–490. https://doi.org/10.1161/CIRCINTERVENTIONS.112.970954
Gao, L., Wang, Y., Liu, Y., Cao, F., & Chen, Y. (2017). Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 89(S1), 574–581. https://doi.org/10.1002/ccd.26934
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
